Targeting Chemokine Receptor CCR4 in Adult T-Cell Leukemia-Lymphoma and Other T-Cell Lymphomas
Open Access
- 27 April 2012
- journal article
- review article
- Published by Springer Nature in Current Hematologic Malignancy Reports
- Vol. 7 (3) , 235-240
Abstract
Peripheral T-cell lymphoma (PTCL) is a group of lymphoid malignancy that remains difficult to treat, as most PTCL becomes refractory or relapses, and thus there is an unmet medical need for novel treatment modalities. CC chemokine receptor 4 (CCR4) is expressed in various types of PTCL including adult T-cell leukemia-lymphoma (ATL), which has the worst prognosis among them. A phase II study of a defucosylated, humanized anti-CCR4 monoclonal antibody, mogamulizumab (KW-0761), yielded an overall response rate of 50 % (13/26) and a median progression-free survival of 5.2 months in relapsed patients with CCR4-positive ATL who had been previously treated with chemotherapy. Mogamulizumab also showed potential efficacy for cutaneous T-cell lymphoma in a US phase I/II study. Further preclinical and clinical investigations are needed to examine whether concomitant use of this novel agent with other agents with different mechanisms of action would be more effective for ATL and other PTCLs.Keywords
This publication has 44 references indexed in Scilit:
- Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL StudyJournal of Clinical Oncology, 2011
- Ethnoepidemiology of HTLV‐1 related diseases: Ethnic determinants of HTLV‐1 susceptibility and its worldwide dispersalCancer Science, 2011
- Clinical Trials for Human T-Cell Lymphotropic Virus Type I–Associated Peripheral T-Cell Lymphoma in JapanSeminars in Hematology, 2010
- Defucosylated Anti-CCR4 Monoclonal Antibody Exerts Potent ADCC against Primary ATLL Cells Mediated by Autologous Human Immune Cells in NOD/Shi-scid, IL-2Rγnull Mice In VivoThe Journal of Immunology, 2009
- Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus MeetingJournal of Clinical Oncology, 2009
- Augmentation of antitumour activity of defucosylated chimeric anti‐CCR4 monoclonal antibody in SCID mouse model of adult T‐cell leukaemia/lymphoma using G‐CSFBritish Journal of Haematology, 2008
- Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemiaOncogene, 2007
- Recent advances in adult T-cell leukemia therapy: focus on a new anti-transferrin receptor monoclonal antibodyLeukemia, 2007
- Daclizumab (anti-Tac, Zenapax) in the treatment of leukemia/lymphomaOncogene, 2007
- Phenotypic analysis of peripheral T cell lymphoma among the JapaneseActa Pathologica Japonica, 1993